Systematic review of available guidelines on fertility preservation of young patients with breast cancer

Asian Pacific Journal of Cancer Prevention

Volumn 16, Issue 3, 2015, Pages 1057-1062

  Haddadi, Mahnaz ^a   Muhammadnejad, Samad ^b   Sadeghi Fazel, Fariba ^c   Zandieh, Zahra ^d   Rahimi, Gohar ^e   Sadighi, Sanambar ^a   Akbari, Parya ^f   Mohagheghi, Mohammad Ali ^a   Mosavi Jarrahi, Alireza ^a,g   Amanpour, Saeid ^a,h  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c RAZI VACCINE AND SERUM RESEARCH INSTITUTE   (Iran)

^d IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e UNIVERSITY OF COLOGNE   (Germany)

^f TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^g SIMON FRASER UNIVERSITY   (Canada)

^h TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Breast cancer; Fertility preservation; Practice guidelines; Young women

Indexed keywords

BREAST TUMOR; EVIDENCE BASED MEDICINE; FEMALE; FERTILITY PRESERVATION; HUMAN; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; QUALITY CONTROL;

BREAST NEOPLASMS; EVIDENCE-BASED MEDICINE; FEMALE; FERTILITY PRESERVATION; HUMANS; PRACTICE GUIDELINES AS TOPIC; QUALITY CONTROL;

EID: 84929347442     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2015.16.3.1057     Document Type: Article

References (54)

1. AGREE Collaboration (2003). Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project. Qual Saf Health Care, 12, 18-23.
2. Ajala T, Rafi J, Larsen-Disney P, et al (2010). Fertility preservation for cancer patients: a review. Obstet Gynecol Int, 2010, 160386.
3. Bedoschi G, Turan V, Oktay K (2013). Utility of GnRH-agonists for fertility preservation in women with operable breast cancer: is it protective?. Curr Breast Cancer Rep, 5, 302-8.
4. Bray F, Ren JS, Masuyer E, et al (2013). Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer, 132, 1133-45.
5. Cardoso F1, Loibl S, Pagani O, et al (2012). The European Society of Breast Cancer Specialists recommendations for the management of young women with breast cancer. Eur J Cancer, 48, 3355-77.
6. Christinat A, Pagani O (2012). Fertility after breast cancer. Maturitas, 73, 191-6.
7. Coccia PF, Altman J, Bhatia S, et al (2012). Adolescent and young adult oncology. JNCCN, 10, 1112-50.
8. Cruz MR, Prestes JC, Gimenes DL, et al (2010). Fertility preservation in women with breast cancer undergoing adjuvant chemotherapy: a systematic review. Fertil Steril, 94, 138-43.
9. Demeestere I, Simon P, Emiliani S, et al (2007). Fertility preservation: successful transplantation of cryopreserved ovarian tissue in a young patient previously treated for Hodgkin's disease. Oncologist, 12, 1437-42.
10. Dizon DS (2009). Quality of life after breast cancer: survivorship and sexuality. Breast J, 15, 500-4.
11. Dolmans MM, Jadoul P, Gilliaux S, et al (2013). A review of 15 years of ovarian tissue bank activities. J Assist Reprod Genet, 30, 305-14.
12. Ethics Committee of the American Society for Reproductive Medicine (2005). Fertility preservation and reproduction in cancer patients. Fertil Steril, 83, 1622-8.
13. Ewertz M, Jensen AB (2010). Late effects of breast cancer treatment and potentials for rehabilitation. Acta Oncol, 50, 187-93.
14. Fields E, Chard J, James D, et al (2013). Fertility [update]: summary of NICE guidance. BMJ, 20, 346-650.
15. Forman EJ, Anders CK, Behera MA (2010). A nationwide survey of oncologists regarding treatment-related infertility and fertility preservation in female cancer patients. Fertil Steril, 94, 1652-6.
16. Goldhirsch A, Ingle JN, Gelber RD, et al (2009). Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009. Ann Oncol, 20, 1319-29.
17. Husseinzadeh N (2013). Preservation of ovarian function in young women with gynecologic cancer desiring future pregnancy: a review. AJCR, 1, 25-37.
18. Husseinzadeh N, Husseinzadeh HD (2013). Preservation of fertility in female cancer patients desiring future child bearing; what is available and what can be offered. World J Oncol, 4, 1-7.
19. Imhof M, Hofstetter G, Bergmeister LH, et al (2004). Cryopreservation of a whole ovary as a strategy for restoring ovarian function. J Assist Reprod Genet, 21, 459-65.
20. Isachenko V, Isachenko E, Reinsberg J, et al (2007). Cryopreservation of human ovarian tissue: comparison of rapid and conventional freezing. Cryobiology, 55, 261-8.
21. ISFP Practice Committee1, Kim SS, Donnez J, et al (2012). Recommendations for fertility preservation in patients with lymphoma, leukemia, and breast cancer. J Assist Reprod Genet, 29, 465-8.
22. Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90.
23. Jemal CK, Johnson R, Litton J, et al (2009). Breast cancer before age 40 years. Semin Oncol, 36, 237-49.
24. Jeruss JS, Woodruff TK (2009). Preservation of fertility in patients with cancer. N Engl J Med, 360, 902-11.
25. Keramatinia A, Mousavi-Jarrahi SH, Hiteh M, et al (2014). Trends in incidence of breast cancer among women under 40 in Asia. Asian Pac J Cancer Prev, 15, 1387-90.
26. Kim SS, Klemp J, Fabian C (2011). Breast cancer and fertility preservation. Fertil Steril, 95, 1535-43.
27. King JW, Davies MC, Roche N, et al (2012). Fertility preservation in women undergoing treatment for breast cancer in the UK: a questionnaire study. Oncologist, 17, 910-16.
28. Klemp JR, and Kim SS (2012). Fertility preservation in young women with breast cancer. J Assist Reprod Genet, 29, 469-72.
29. Klock SC, Zhang JX, Kazer RR (2010). Fertility preservation for female cancer patients: early clinical experience. Fertil Steril, 94, 149-55.
30. Lange S, Hurst BS, Matthews ML, et al (2013). Fertility preservation in patients with gynecologic cancer-part I: the impact of gynecologic malignancies on fertility. Postgraduate Obstet Gynecol, 33, 1-7.
31. Lange S, Hurst BS, Matthews ML, et al (2013). Fertility preservation in patients with gynecologic cancer-part ii: current options and the ethics of oncofertility. Postgraduate Obstet Gynecol, 33, 1-5.
32. Leclere B1, Molinie F, Tretarre B, et al (2013). Trends in incidence of breast cancer among women under 40 in seven European countries: a GRELL cooperative study. Cancer Epidemiol, 37, 544-9.
33. Lee SJ, Schover LR, Partridge AH, et al (2006). American society of clinical oncology recommendations on fertility preservation in cancer patients. J Clin Onco, 24, 2917-31.
34. Lobo RA (2005). Potential options for preservation of fertility in women. N Engl J Med, 353, 64-73.
35. Loren AW, Mangu PB, Beck LN, et al (2013). Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol, 31, 2500-10.
36. Maltaris T, Seufert R, Fischl F, et al (2007). The effect of cancer treatment on female fertility and strategies for preserving fertility. Eur J Obstet Gynecol Reprod Biol, 130, 148-55.
37. Michaeli J, Weintraub M, Gross E, et al (2012). Fertility preservation in girls. Obstet Gynecol Int, 2012, 139193.
38. National Collaborating Center for Women's and Children's Health (UK) (2004). Fertility: Assessment and Treatment for People with Fertility Problems. RCOG Press.
39. Oktay K, Buyuk E, Davis O, et al (2003). Fertility preservation in breast cancer patients: IVF and embryo cryopreservation after ovarian stimulation with tamoxifen. Hum Reprod, 18, 90-5.
40. Oktay K, Buyuk E, Libertella N, et al (2005). Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. J Clin Oncol, 23, 4347-53.
41. Partridge AH (2008). Fertility preservation: a vital survivorship issue for young women with breast cancer. J Clin Oncol, 26, 2612-13.
42. Peate M, Meiser B, Friedlander M, et al (2011). It's now or never: fertility-related knowledge, decision-making preferences, and treatment intentions in young women with breast cancer-an Australian fertility decision aid collaborative group study. J Clin Oncol, 29, 1670-77.
43. Peccatori FA, Pup LD, Salvagno F, et al (2012). Fertility preservation methods in breast cancer. Breast Care, 7, 197-202.
44. Pentheroudakis G, Orecchia R, Hoekstra HJ, et al (2010). Cancer, fertility and pregnancy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol, 21, 266-73.
45. Posada MN, Kolp L, García JE (2001). Fertility options for female cancer patients: facts and fiction. Fertil Steril, 75, 647-53.
46. Rahimi G, Isachenko V, Kreienberg R, et al (2010). Re-vascularisation in human ovarian tissue after conventional freezing or vitrification and xenotransplantation. Eur J Obstet Gynecol Reprod Biol, 149, 63-7.
47. Reinecke J (2013). On the frontlines of cancer & fertility: A Report on the 2013 ASRM Meeting. [www.asram.org]. LIVESTRONG.
48. Rodriguez-Wallberg KA, Oktay K (2010). Fertility preservation in women with breast cancer. Clin Obstet Gynecol, 53, 753-62.
49. Ronn R, and Holzer H (2013). Oncofertility in Canada: an overview of Canadian practice and suggested action plan. Curr Oncol, 20, 465-74.
50. Sonmezer M, Oktay K (2004). Fertility preservation in female patients. Hum Reprod Update, 10, 251-66.
51. Sonmezer M, Oktay K (2006). Fertility preservation in young women undergoing breast cancer therapy. Oncologist, 11, 422-34.
52. Theriault RL, Carlson RW, Allred C, et al (2013). Breast cancer, version 3.2013: featured updates to the NCCN guidelines. J Natl Compr Canc Netw, 11, 753-60.
53. Von Wolff M, Dittrich R, Denschlag D, et al (2011). Fertility preservation in women-a practical guide to preservation techniques and therapeutic strategies in breast cancer, Hodgkin's lymphoma and borderline ovarian tumours by the fertility preservation network FertiPROTEKT. Arch Gynecol Obstet, 284, 427-35.
54. Wallace WH, Anderson RA, Irvine DS (2005). Fertility preservation for young patients with cancer: who is at risk and what can be offered?. Lancet Oncol, 6, 209-18.